以滤纸为模板合成新型介孔生物活性玻璃微管材料

用快速滤纸为生物模板,通过先浸渍后焙烧的方法合成了介孔生物活性玻璃微管材料。快速滤纸的管状结构被完美复制,其管壁为生成的介孔生物玻璃材料。通过在合成过程中引入铁元素可以使材料具有一定的磁性。材料的形貌、结构和磁性通过扫描电镜、粉末X射线衍射、透射电镜、氮气吸附-脱附曲线,红外光谱和磁滞回线进行了表征。并且通过模拟体液浸泡方法考察了其矿化能力,以地塞米松为模型药物考察其释药能力和生物相容性。合成的介孔生物活性玻璃微管材料具有复杂的管状多级结构、快速的矿化能力和良好的生物相容性,并具备一定的磁性,是一种不可多得的药物缓释材料。     

磁性有序介孔炭的合成及新应用

有序介孔炭作为一类崭新的功能材料,因具有高比表面积、孔径分布集中、孔径结构可调、大孔容、高度热稳定性和机械稳定性等优异特性而备受瞩目,广泛应用于水体净化、催化及光、电、磁等领域。其极佳的生物相容性使其在药物负载领域有巨大的潜在应用价值。根据磁性有序介孔炭材料的最新研究动态和应用研究热点,本文综述了磁性有序介孔炭合成作用机理、药物负载效率和介孔结构(如比表面、孔容、孔径分布)制约因素。讨论分析了各种合成方法的优劣和孔结构参数制约载药量的研究瓶颈。并着重对磁性有序介孔炭在医药领域的新应用进行了阐述和评价。旨在为探讨磁性有序介孔炭在优化合成工艺技术参数、提高药物负载量和靶向释药应用趋势方面提供理论导向。     

球形生物活性玻璃作为运输载体的研究

球形纳米生物活性玻璃(BGN)含有硅、钙和磷等元素,具有可控的形貌和粒径、有序的介孔结构、较高比表面积和孔隙率、良好的生物相容性与成骨活性,已被广泛用于骨修复和牙科诊疗。BGN还可掺杂不同金属离子以增强成骨性、成血管性等,或使其具备抗菌性或生物成像能力。同时,球形、有序介孔结构、纳米级的尺寸和高比表面积有利于装载药物或生物因子并进入细胞,使其具有潜在的高负载能力和靶向治疗能力。但由于难以制备粒径较小的单分散BGN,且纳米级颗粒普遍存在团聚问题,对生物体的影响也不完全明确,所以,BGN尚不能作为临床药物载体被利用,相关的研究仍需深入。本文综述了近年来BGN的制备技术、负载能力、生物相容性和生物活性等方面研究及应用现状,并对其发展方向进行了展望。     

磁性介孔材料的研究进展

磁性介孔材料兼具介孔材料和磁性材料的双重优势,如高比表面积、孔径均一、高吸附性和可磁分离性,具有广泛的应用前景和重大的研究意义,受到化学和材料工作者的极大关注。本文综述了磁性介孔材料的制备方法及其改性研究,同时介绍了磁性介孔材料在污水处理、催化反应、药物控释和生物分子的分离提纯等领域的一些应用进展。     

有序介孔材料在生物医药领域中的应用

本文简述了有序介孔材料的特性,详细介绍了其在生物医药领域中的应用研究,如用于酶的固定化、生物传感器、药物的包埋和控释、生物活性材料、生物分子的吸附和分离等,阐述了不同类型的有序介孔材料在这些应用中的性能以及为适用于该领域应用进行的材料开发和结构修饰,最后对材料的改进和应用前景进行了展望。     

聚乳酸接枝改性纳米生物玻璃/PLGA复合材料的制备、表面性质及生物活性

以丙交酯开环聚合原位接枝改性的纳米生物玻璃(PLLA-g-BG)与聚丙交酯-乙交酯(PLGA)复合材料为研究对象, 采用TGA, ESEM和EDX分析其接枝率, 粒子分散性和表面元素分布, 通过将兔成骨细胞种植于材料膜表面进行体外培养, 采用荧光染色法、NIH Image J图像分析软件、MTT法和流式细胞术等手段检测细胞在材料表面的平均黏附数量、扩展面积比、增殖能力和细胞周期的变化, 综合评价新型改性纳米复合材料的生物相容性和生物活性. 结果表明, 聚乳酸表面接枝改性可明显改善纳米生物玻璃粒子的团聚; PLGA中掺入一定比例的改性PLLA-g-BG可明显促进兔成骨细胞的黏附、扩展与增殖; 改性纳米生物玻璃的应用可提高生物可降解聚酯材料的生物相容性和生物活性.     

离子掺杂介孔生物活性玻璃的合成及应用研究

骨填充和骨替代生物材料的研究与开发是骨修复领域重要的研究方向之一。介孔生物活性玻璃（MBG）因其具有良好的生物活性以及可调节的孔径和有序的介孔结构,将在骨修复再生中发挥重要作用。通过不同的制备加工方法能得到纤维、支架、中空结构或纳米颗粒结构的MBG;大量研究表明,在MBG中掺杂少量的治疗性无机离子,能赋予它们更多的生物学特性,包括成骨、抗菌、抗炎、止血或抗癌特性;而且无机离子掺杂的MBG作为支架或纳米颗粒加工后,仍然具有出色的生物活性反应。此外,通过在介孔结构内负载生物活性分子、治疗药物和干细胞可进一步改善MBG的性能。本文介绍了近年来MBG的合成、金属离子掺杂MBG的抗菌性能以及MBG在其他方面的应用进展。     

羟基磷灰石/胶原矿化机理的研究进展

仿生合成的羟基磷灰石(HAp)/胶原复合材料的结构和成分与天然骨相似,具有很好的生物相容性、生物活性和生物可降解性,有望成为新一代的骨替代材料。羟基磷灰石/胶原矿化过程其实质是晶体在自组装的胶原纤维上形成的过程,但这一过程在体内是如何进行的至今仍然不清楚。对胶原矿化机理的研究能为制备具有更优越结构和功能的新型骨替代材料提供理论参考。本文概述了羟基磷灰石/胶原矿化机理的研究进展。     

以大蓟髓芯为模板制备复合孔生物活性玻璃及其体外成骨性能

以天然植物大蓟髓芯为大孔模板, 以嵌段共聚物为介孔软模板, 制备了孔径为60~100 μm、孔壁为介孔相的高度有序多级复合孔生物活性玻璃. 用扫描电子显微镜(SEM)、粉末X射线衍射仪(XRD)、高分辨率透射电镜(HRTEM)及N2吸附-脱附等测试手段对合成的样品进行了表征. 结果表明, 合成的材料精确地复制了植物模板的形貌, 同时具有较高的比表面积和较大的孔容. 通过体外模拟生理体液测试表明, 这种复合孔生物活性玻璃可诱导羟基磷灰石晶体在其表面形成, 具有良好的体外成骨性能, 因而在骨组织修复方面具有潜在应用前景.     

根霉菌为模板矿化合成纳米结构SiO2材料的研究

在人工培养条件下,以真核生物细胞根霉菌为模板,以正硅酸乙酯(TEOS)作为硅源进行了生物矿化实验,并采用TEM、SEM、FTIR、EDX、TGA等手段对实验结果进行了表征。结果表明,TEOS/培养基浓度为80mg/L时,矿化合成了一种厚度为5nm的管状SiO2纳米结构材料。本实验为利用生物细胞模板合成介观尺寸有序的SiO2纳米结构材料提供了技术基础。     

Bio-templated synthesis of highly ordered macro-mesoporous silica material for sustained drug delivery

The bimodal porous structured silica materials consisting of macropores with the diameter of 5–20 μm and framework-like mesopores with the diameter of 4.7–6.0 nm were prepared using natural Manchurian ash and mango linin as macropored hard templates and P123 as mesopore soft templates, respectively. The macroporous structures of Manchurian ash and mango linin were replicated with the walls containing highly ordered mesoporous silica as well. As-synthesized dual porous silica was characterized by scanning electron microscope (SEM), powder X-ray diffraction (XRD), transmission electron microscope (TEM) and nitrogen adsorption/desorption, fourier transform IR (FTIR) spectroscopy, and thermo-gravimetric analyzer (TGA). Ibuprofen (Ibu) was employed as a model drug and the release profiles showed that the dual porous material had a sustained drug delivery capability. And such highly ordered dual pore silica materials may have potential applications for bimolecular adsorption/separation and tissue repairing.     

Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu3+) as a drug carrier

Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu) was successfully synthesized. The obtained MCS: Eu(3+) was performed as a drug delivery carrier to investigate the drug storage/release properties using ibuprofen (IBU) as the model drug. The structural, morphological, textural, and optical properties were well characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), N(2) adsorption/desorption, and photoluminescence (PL) spectra, respectively. The results reveal that the MCS: Eu exhibits the typical ordered characteristics of the mesostructure. This composite shows a sustained release profile with IBU as the model drug. The IBU-loaded samples still present red luminescence of Eu(3+) ((5)D(0)-(7)F(1,2)) under UV irradiation. The emission intensities of Eu(3+) in the drug carrier system vary with the amount of released IBU, making the drug release easily tracked and monitored. The system demonstrates a great potential for drug delivery and disease therapy.     

Smart Soft‐Templating Synthesis of Hollow Mesoporous Bioactive Glass Spheres

Hollow bioactive glass spheres with mesoporous shells were prepared by using dual soft templates, a diblock co‐polymer poly(styrene‐b‐acrylic acid) (PS‐b‐PAA) and a cationic surfactant cetyltrimethylammonium bromide (CTAB). Hollow mesoporous bioactive glass (HMBG) spheres comprise the large hollow interior with vertical mesochannels in shell, which realize large uptake of drugs and their sustained release. The formation of hydroxyapatite layer on the surface of HMBG particles shows the clear evidence for promising application in bone regeneration.     

A novel pH-responsive controlled release system based on mesoporous silica coated with hydroxyapatite

With well bioactive and nontoxic, hydroxyapatite (HAp) was employed to seal the nanopores of mesoporous silica (MCM-41) to realize the pH-responsive controlled release. First, MCM-41 was modified with cationic polymer, poly-(diallyldimethylammoniumchloride) (PA). And after the addition of Ca²⁺/PO₄ ^3?, HAp precipitation can take place based on the cationic sites derived from PA. It is a simple and effective way to obtain HAp coating MCM-41 system (MHAs). The structure of the system was characterized by X-ray diffraction, scanning electron microscope, transmission electron microscope, N₂ adsorption–desorption and so on. Metformin hydrochloride was used as the model drug, and the drug release performance and the release kinetics of the system were investigated in detail. Because of the degradation of HAp under acid condition, the drug loading MHAs showed a well pH-sensitive controlled release behavior. From above investigation, MHAs is a promising platform to construct a pH-responsive controlled drug delivery system, especially for some low pH tissues, such as inflammatory and tumor.     

Uniform and size-tunable mesoporous silica with fibrous morphology for drug delivery

A family of mesoporous silica microspheres with fibrous morphology and different particle sizes ranging from about 400 to 900 nm has been successfully synthesized through a facile self-assembly process. The structural, morphological, and textural properties of the samples were well characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), nuclear magnetic resonance (NMR), Fourier transform infrared spectroscopy (FT-IR), N(2) adsorption/desorption, and thermal gravimetry (TG). The results reveal that this silica-based mesoporous material exhibits excellent physical properties, including a fibrous spherical morphology, good thermal stability, large pore volume, high specific surface area and narrow size distribution. Additionally, the size and textural properties can be tuned by altering the silica precursor/template molar ratio. The formation and the self-assembly evolution process have also been proposed. The obtained materials were further used as a drug delivery carrier to investigate the in vitro drug release properties using doxorubicin (DOX) as a representative model drug. It was found that this kind of silica exhibits good biocompatibility and obvious sustained drug release properties, suggesting its potential application in biological fields.     

Integration of Mesoporous Bioactive Glass Nanoparticles and Curcumin into PHBV Microspheres as Biocompatible Composite for Drug Delivery Applications

Bioactive glasses (BGs) are being increasingly considered for biomedical applications. One convenient approach to utilize BGs in tissue engineering and drug delivery involves their combination with organic biomaterials in order to form composites with enhanced biocompatibility and biodegradability. In this work, mesoporous bioactive glass nanoparticles (MBGN) have been merged with polyhydroxyalkanoate microspheres with the purpose to develop drug carriers. The composite carriers (microspheres) were loaded with curcumin as a model drug. The toxicity and delivery rate of composite microspheres were tested in vitro, reaching a curcumin loading efficiency of over 90% and an improving of biocompatibility of different concentrations of MBGN due to its administrations through the composite. The composite microspheres were tested in terms of controlled release, biocompatibility and bioactivity. Our results demonstrate that the composite microspheres can be potentially used in biomedicine due to their dual effects: bioactivity (due to the presence of MBGN) and curcumin release capability.     

Synthesis of hierarchical sieve-like mesoporous silica nanoparticle aggregates via centrifugal method for drug delivery system

A facile approach towards the scaled-up synthesis of a novel hierarchical sieve-like structure of mesoporous silica nanoparticle aggregates (hsMSNA) with high drug encapsulation efficiency and sustained release behaviors acting as a drug delivery system in the field of nanomedicine.     

Effects of acidic catalysts on the microstructure and biological property of sol–gel bioactive glass microspheres

Sol–gel bioactive glasses have been developed for bone tissue regeneration and drug delivery systems as they have the unique mesoporous structure and high bioactivity in vitro. To develop more reliable drug delivery and bone tissue repair systems, it is necessary to control the morphology and microstructure of bioactive glasses. For this purpose, bioactive glass microspheres (BGMs) were prepared by a sol–gel co-template technology using acids as catalysts. We studied the effects of different acids (citric acid, lactic acid and acetic acid) on the microstructure and apatite-forming bioactivity of BGM. The apatite-forming bioactivity was carried out in simulated body fluid (SBF). The microstructure and apatite-forming bioactivity of BGMs were characterized by various methods. Results showed that acetic acid had little effect on the structure and bioactivity of BGMs. Differently, the morphology and microstructure of BGMs could be controlled by changing citric acid and lactic acid concentrations. In vitro bioactivity test indicated that citric acid and lactic acid derived BGMs possessed the better apatite-forming capacity than that derived by acetic acid.     

Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15

Ordered mesoporous materials exhibit potential features to be used as controlled drug delivery systems, including their wide range of chemical compositions and their outstanding textural and structural properties. Therefore, it is possible to control the drug release kinetics by tailoring such parameters. In this paper, mesoporous materials such as MCM-48 and SBA-15, which present different pore sizes (3.7 and 8.8 nm) and structural characteristics (3D-bicontinuous cubic and 2D-hexagonal, respectively) have been synthesized to evaluate their application as drug delivery system and to determine their influence on release kinetic of ibuprofen. Moreover, a chemical modification of the SBA-15 mesoporous material with octadecyltrimethoxysilane has also been performed to study its influence on the release rate of ibuprofen. The structural characteristics (3D cubic and 2D hexagonal pore system) do not affect the release kinetic profiles of ibuprofen. On the contrary, the pore size affects highly to the release kinetic profiles from first-order kinetic to zero-order kinetic for MCM-48 and SBA-15, respectively. Moreover, the importance of surface functionalization was demonstrate through the very fast delivery of ibuprofen from SBA-15 mesoporous materials functionalized with octadecyl chains.